Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial | Acute Kidney Injury | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.239.150.57. Please contact the publisher to request reinstatement.
1.
Hoste  EA, Bagshaw  SM, Bellomo  R,  et al.  Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study.  Intensive Care Med. 2015;41(8):1411-1423.PubMedGoogle ScholarCrossref
2.
Bellomo  R, Cass  A, Cole  L,  et al; RENAL Replacement Therapy Study Investigators.  Intensity of continuous renal replacement therapy in critically ill patients.  N Engl J Med. 2009;361(17):1627-1638.PubMedGoogle ScholarCrossref
3.
Palevsky  PM, Zhang  JH, O’Connor  TZ,  et al; VA/NIH Acute Renal Failure Trial Network.  Intensity of renal support in critically ill patients with acute kidney injury.  N Engl J Med. 2008;359(1):7-20.PubMedGoogle ScholarCrossref
4.
Jun  M, Heerspink  HJ, Ninomiya  T,  et al.  Intensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis.  Clin J Am Soc Nephrol. 2010;5(6):956-963.PubMedGoogle ScholarCrossref
5.
KDIGO AKI Work Group.  KDIGO clinical practice guideline for acute kidney injury.  Kidney Int Suppl. 2012;2:1-138.Google ScholarCrossref
6.
Ronco  C, Ricci  Z, De Backer  D,  et al.  Renal replacement therapy in acute kidney injury: controversy and consensus.  Crit Care. 2015;19:146.PubMedGoogle ScholarCrossref
7.
Karvellas  CJ, Farhat  MR, Sajjad  I,  et al.  A comparison of early vs late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis.  Crit Care. 2011;15(1):R72.PubMedGoogle ScholarCrossref
8.
Bouman  CS, Oudemans-Van Straaten  HM, Tijssen  JG, Zandstra  DF, Kesecioglu  J.  Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial.  Crit Care Med. 2002;30(10):2205-2211.PubMedGoogle ScholarCrossref
9.
Jamale  TE, Hase  NK, Kulkarni  M,  et al.  Earlier-start vs usual-start dialysis in patients with community-acquired acute kidney injury: a randomized controlled trial.  Am J Kidney Dis. 2013;62(6):1116-1121.PubMedGoogle ScholarCrossref
10.
Wald  R, Adhikari  NK, Smith  OM,  et al; Canadian Critical Care Trials Group.  Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury.  Kidney Int. 2015;88(4):897-904.PubMedGoogle ScholarCrossref
11.
Gettings  LG, Reynolds  HN, Scalea  T.  Outcome in posttraumatic acute renal failure when continuous renal replacement therapy is applied early vs late.  Intensive Care Med. 1999;25(8):805-813.PubMedGoogle ScholarCrossref
12.
Bagshaw  SM, Uchino  S, Bellomo  R,  et al; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.  Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury.  J Crit Care. 2009;24(1):129-140.PubMedGoogle ScholarCrossref
13.
Shiao  CC, Wu  VC, Li  WY,  et al; National Taiwan University Surgical Intensive Care Unit-Associated Renal Failure Study Group.  Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery.  Crit Care. 2009;13(5):R171.PubMedGoogle ScholarCrossref
14.
Liu  KD, Himmelfarb  J, Paganini  E,  et al.  Timing of initiation of dialysis in critically ill patients with acute kidney injury.  Clin J Am Soc Nephrol. 2006;1(5):915-919.PubMedGoogle ScholarCrossref
15.
Chou  YH, Huang  TM, Wu  VC,  et al; NSARF Study Group.  Impact of timing of renal replacement therapy initiation on outcome of septic acute kidney injury.  Crit Care. 2011;15(3):R134.PubMedGoogle ScholarCrossref
16.
Elahi  MM, Lim  MY, Joseph  RN, Dhannapuneni  RR, Spyt  TJ.  Early hemofiltration improves survival in postcardiotomy patients with acute renal failure.  Eur J Cardiothorac Surg. 2004;26(5):1027-1031.PubMedGoogle ScholarCrossref
17.
Demirkiliç  U, Kuralay  E, Yenicesu  M,  et al.  Timing of replacement therapy for acute renal failure after cardiac surgery.  J Card Surg. 2004;19(1):17-20.PubMedGoogle ScholarCrossref
18.
Sugahara  S, Suzuki  H.  Early start on continuous hemodialysis therapy improves survival rate in patients with acute renal failure following coronary bypass surgery.  Hemodial Int. 2004;8(4):320-325.PubMedGoogle ScholarCrossref
19.
Zarbock  A, Gerß  J, Van Aken  H, Boanta  A, Kellum  JA, Meersch  M.  Early vs late initiation of renal replacement therapy in critically ill patients with acute kidney injury (the ELAIN trial): study protocol for a randomized controlled trial.  Trials. 2016;17(1):148.PubMedGoogle ScholarCrossref
20.
Wassmer  G.  Planning and analyzing adaptive group sequential survival trials.  Biom J. 2006;48(4):714-729.PubMedGoogle ScholarCrossref
21.
Lehmacher  W, Wassmer  G.  Adaptive sample size calculations in group sequential trials.  Biometrics. 1999;55(4):1286-1290.PubMedGoogle ScholarCrossref
22.
Simmons  EM, Himmelfarb  J, Sezer  MT,  et al; PICARD Study Group.  Plasma cytokine levels predict mortality in patients with acute renal failure.  Kidney Int. 2004;65(4):1357-1365.PubMedGoogle ScholarCrossref
23.
Murugan  R, Karajala-Subramanyam  V, Lee  M,  et al; Genetic and Inflammatory Markers of Sepsis (GenIMS) Investigators.  Acute kidney injury in nonsevere pneumonia is associated with an increased immune response and lower survival.  Kidney Int. 2010;77(6):527-535.PubMedGoogle ScholarCrossref
24.
Gangemi  S, Mallamace  A, Minciullo  PL,  et al.  Involvement of interleukin-18 in patients on maintenance haemodialysis.  Am J Nephrol. 2002;22(5-6):417-421.PubMedGoogle ScholarCrossref
25.
Bacher  M, Metz  CN, Calandra  T,  et al.  An essential regulatory role for macrophage migration inhibitory factor in T cell activation.  Proc Natl Acad Sci U S A. 1996;93(15):7849-7854.PubMedGoogle ScholarCrossref
26.
Kellum  JA, Mehta  RL, Levin  A,  et al; Acute Kidney Injury Network (AKIN).  Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, 3-step modified Delphi process.  Clin J Am Soc Nephrol. 2008;3(3):887-894.PubMedGoogle ScholarCrossref
27.
Gibney  N, Hoste  E, Burdmann  EA,  et al.  Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions.  Clin J Am Soc Nephrol. 2008;3(3):876-880.PubMedGoogle ScholarCrossref
28.
Clark  WR, Letteri  JJ, Uchino  S, Bellomo  R, Ronco  C.  Recent clinical advances in the management of critically ill patients with acute renal failure.  Blood Purif. 2006;24(5-6):487-498.PubMedGoogle ScholarCrossref
29.
Matson  J, Zydney  A, Honoré  PM.  Blood filtration: new opportunities and the implications of systems biology.  Crit Care Resusc. 2004;6(3):209-217.PubMedGoogle Scholar
30.
Hoste  EA, Clermont  G, Kersten  A,  et al.  RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis.  Crit Care. 2006;10(3):R73.PubMedGoogle ScholarCrossref
31.
Cruz  DN, de Cal  M, Garzotto  F,  et al.  Plasma neutrophil gelatinase–associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population.  Intensive Care Med. 2010;36(3):444-451.PubMedGoogle ScholarCrossref
32.
Cruz  DN, de Geus  HR, Bagshaw  SM.  Biomarker strategies to predict need for renal replacement therapy in acute kidney injury.  Semin Dial. 2011;24(2):124-131.PubMedGoogle ScholarCrossref
33.
Bouchard  J, Soroko  SB, Chertow  GM,  et al; Program to Improve Care in Acute Renal Disease (PICARD) Study Group.  Fluid accumulation, survival, and recovery of kidney function in critically ill patients with acute kidney injury.  Kidney Int. 2009;76(4):422-427.PubMedGoogle ScholarCrossref
34.
Liu  KD, Glidden  DV, Eisner  MD,  et al; National Heart, Lung, and Blood Institute ARDS Network Clinical Trials Group.  Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury.  Crit Care Med. 2007;35(12):2755-2761.PubMedGoogle ScholarCrossref
35.
Kellum  JA, Kong  L, Fink  MP,  et al; GenIMS Investigators.  Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study.  Arch Intern Med. 2007;167(15):1655-1663.PubMedGoogle ScholarCrossref
36.
Murugan  R, Wen  X, Shah  N,  et al; Biological Markers for Recovery of Kidney (BioMaRK) Study Investigators.  Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy.  Nephrol Dial Transplant. 2014;29(10):1854-1864.PubMedGoogle ScholarCrossref
37.
Liu  KD, Altmann  C, Smits  G,  et al.  Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study.  Crit Care. 2009;13(4):R104.PubMedGoogle ScholarCrossref
38.
Liangos  O, Kolyada  A, Tighiouart  H, Perianayagam  MC, Wald  R, Jaber  BL.  Interleukin-8 and acute kidney injury following cardiopulmonary bypass: a prospective cohort study.  Nephron Clin Pract. 2009;113(3):c148-c154.PubMedGoogle ScholarCrossref
39.
Kwon  O, Molitoris  BA, Pescovitz  M, Kelly  KJ.  Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts.  Am J Kidney Dis. 2003;41(5):1074-1087.PubMedGoogle ScholarCrossref
40.
Chawla  LS, Seneff  MG, Nelson  DR,  et al.  Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis.  Clin J Am Soc Nephrol. 2007;2(1):22-30.PubMedGoogle ScholarCrossref
Original Investigation
Caring for the Critically Ill Patient
May 24/31, 2016

Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial

Author Affiliations
  • 1Department of Anaesthesiology, Intensive Care Medicine and Pain Medicine, University Hospital Münster, Germany
  • 2Center for Critical Care Nephrology, Department of Critical Care Medicine, University of Pittsburgh, Pennsylvania
  • 3Department of Internal Medicine D, University Hospital Münster, Germany
  • 4Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany
JAMA. 2016;315(20):2190-2199. doi:10.1001/jama.2016.5828
Abstract

Importance  Optimal timing of initiation of renal replacement therapy (RRT) for severe acute kidney injury (AKI) but without life-threatening indications is still unknown.

Objective  To determine whether early initiation of RRT in patients who are critically ill with AKI reduces 90-day all-cause mortality.

Design, Setting, and Participants  Single-center randomized clinical trial of 231 critically ill patients with AKI Kidney Disease: Improving Global Outcomes (KDIGO) stage 2 (≥2 times baseline or urinary output <0.5 mL/kg/h for ≥12 hours) and plasma neutrophil gelatinase–associated lipocalin level higher than 150 ng/mL enrolled between August 2013 and June 2015 from a university hospital in Germany.

Interventions  Early (within 8 hours of diagnosis of KDIGO stage 2; n = 112) or delayed (within 12 hours of stage 3 AKI or no initiation; n = 119) initiation of RRT.

Main Outcomes and Measures  The primary end point was mortality at 90 days after randomization. Secondary end points included 28- and 60-day mortality, clinical evidence of organ dysfunction, recovery of renal function, requirement of RRT after day 90, duration of renal support, and intensive care unit (ICU) and hospital length of stay.

Results  Among 231 patients (mean age, 67 years; men, 146 [63.2%]), all patients in the early group (n = 112) and 108 of 119 patients (90.8%) in the delayed group received RRT. All patients completed follow-up at 90 days. Median time (Q1, Q3) from meeting full eligibility criteria to RRT initiation was significantly shorter in the early group (6.0 hours [Q1, Q3: 4.0, 7.0]) than in the delayed group (25.5 h [Q1, Q3: 18.8, 40.3]; difference, −21.0 [95% CI, −24.0 to −18.0]; P < .001). Early initiation of RRT significantly reduced 90-day mortality (44 of 112 patients [39.3%]) compared with delayed initiation of RRT (65 of 119 patients [54.7%]; hazard ratio [HR], 0.66 [95% CI, 0.45 to 0.97]; difference, −15.4% [95% CI, −28.1% to −2.6%]; P = .03). More patients in the early group recovered renal function by day 90 (60 of 112 patients [53.6%] in the early group vs 46 of 119 patients [38.7%] in the delayed group; odds ratio [OR], 0.55 [95% CI, 0.32 to 0. 93]; difference, 14.9% [95% CI, 2.2% to 27.6%]; P = .02). Duration of RRT and length of hospital stay were significantly shorter in the early group than in the delayed group (RRT: 9 days [Q1, Q3: 4, 44] in the early group vs 25 days [Q1, Q3: 7, >90] in the delayed group; P = .04; HR, 0.69 [95% CI, 0.48 to 1.00]; difference, −18 days [95% CI, −41 to 4]; hospital stay: 51 days [Q1, Q3: 31, 74] in the early group vs 82 days [Q1, Q3: 67, >90] in the delayed group; P < .001; HR, 0.34 [95% CI, 0.22 to 0.52]; difference, −37 days [95% CI, −∞ to −19.5]), but there was no significant effect on requirement of RRT after day 90, organ dysfunction, and length of ICU stay.

Conclusions and Relevance  Among critically ill patients with AKI, early RRT compared with delayed initiation of RRT reduced mortality over the first 90 days. Further multicenter trials of this intervention are warranted.

Trial Registration  German Clinical Trial Registry Identifier: DRKS00004367

×